WASHINGTON, July 02, 2025 (GLOBE NEWSWIRE) — The Association of Corporate Counsel (ACC), the world's premier organization for in-house legal professionals, is proud to announce the launch of the ACC AI Center of Excellence for In-House Counsel, a dynamic, member-driven resource designed to support in-house counsel as they navigate the evolving landscape of artificial intelligence. […]
(NASDAQ:VYNE), BRIDGEWATER, N.J., July 02, 2025 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need, today provided a program update for VYN202 following the clinical hold issued by the U.S. Food and
VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202 GlobeNewswire July 02, 2025 BRIDGEWATER, N.J., July 02, 2025 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need, today provided a program
ASSOCIATION OF CORPORATE COUNSEL (ACC) LAUNCHES AI CENTER OF EXCELLENCE TO EMPOWER IN-HOUSE LEGAL PROFESSIONALS GlobeNewswire July 02, 2025 WASHINGTON, July 02, 2025 (GLOBE NEWSWIRE) — The Association of Corporate Counsel (ACC), the world's premier organization for in-house legal professionals, is proud to announce the launch of the ACC AI Center of Excellence for In-House
Hivello buys back 13.5M HVLO under Buy & Burn initiative GlobeNewswire July 02, 2025 TORONTO, July 02, 2025 (GLOBE NEWSWIRE) — Blockmate Ventures Inc (TSX.V: MATE) (OTCQB: MATEF) (FSE: 8MH1) (“Blockmate” or the “Company“) is pleased to announce that its investee, Hivello Holdings, has completed the first batch of its quarterly Buy & Burn initiative,
NEW YORK, NY / ACCESS Newswire / July 2, 2025 / If you suffered a loss on your 3D Systems Corporation (NYSE:DDD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/3d-systems-corporation-lawsuit-submission-form?prid=155225&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / July 2, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=155217&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / July 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) concerning possible violations of federal securities laws. BioPharma Dive published a report on Cytokinetics on May 2, 2025, and stated that, "The Food and Drug Administration has
With freedom as a universal desire being celebrated this month, Kevin Guest, Executive Chairman ofUSANA Health Sciences (NYSE: USNA), is inspiring individuals and families to celebrate freedom on a personal level for self-care. https://mma.prnewswire.com/media/1604818/All_The_Right_Reasons_Cover.jpg Research reveals countless global celebrations honoring freedom-from America's Independence Day on July 4 to the unifying spirit of Canada Day on
NEW YORK, NY / ACCESS Newswire / July 2, 2025 / If you suffered a loss on your Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=155216&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or